Loading...
XNAS
ALGN
Market cap12bUSD
Jul 22, Last price  
172.46USD
1D
-2.84%
1Q
-9.55%
Jan 2017
79.40%
IPO
854.93%
Name

Align Technology Inc

Chart & performance

D1W1MN
XNAS:ALGN chart
P/E
30.10
P/S
3.06
EPS
5.73
Div yield, %
Shrs. gr., 5y
-1.74%
Rev. gr., 5y
10.30%
Revenues
4.03b
+0.90%
206,354,000284,332,000303,976,000312,333,000387,126,000479,741,000560,041,000660,206,000761,653,000845,486,0001,079,874,0001,473,413,0001,966,492,0002,406,796,0002,471,941,0003,952,584,0003,734,635,0003,862,260,0003,999,012,0004,034,964,000
Net income
410m
-2.61%
-34,963,00035,724,00079,987,000-31,269,00074,253,00066,716,00058,691,00064,295,000145,832,000144,020,000189,682,000231,418,000400,235,000442,776,0001,775,888,000772,020,000361,573,000445,053,000421,362,000410,351,000
CFO
593m
-19.64%
-14,030,00052,777,00039,746,00074,165,000129,529,000130,469,000133,778,000185,976,000226,899,000237,997,000247,654,000438,539,000554,681,000747,270,000662,174,0001,172,544,000568,732,000785,776,000738,231,000593,223,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Align Technology, Inc., a prominent medical device company, is dedicated to developing, producing, and commercializing innovative solutions for dental professionals. Its core offerings include the well-known Invisalign clear aligner system and the iTero line of intraoral scanners, complemented by associated services. The company caters to orthodontists, general dentists, and practitioners specializing in restorative and aesthetic dentistry. Its operations are primarily organized into two divisions: The Clear Aligner segment encompasses a comprehensive range of Invisalign products. This includes full treatment solutions like Invisalign comprehensive, tailored for adolescent patients and incorporating advanced features such as mandibular advancement, compliance indicators, and compensation for tooth eruption. It also offers specialized packages for younger children (typically ages seven to ten) with mixed dentition, known as Invisalign First Phase I and Invisalign First Comprehensive Phase 2. Beyond these extensive treatments, the segment provides less comprehensive options, including Invisalign moderate, lite, express packages, and Invisalign Go. Additionally, it supplies non-case related items such as retention devices, charges for Invisalign training, and sells supplementary products like cleaning materials and adjusting instruments utilized by dental professionals during treatment. The Scanners and Services segment focuses on the iTero scanner, a unified hardware platform equipped with various software functionalities for both restorative and orthodontic procedures. Its software for restorative dentistry serves general practitioners, prosthodontists, periodontists, and oral surgeons, while the orthodontic software aids practitioners in digital record keeping, diagnosis, and the creation of printed models and retainers. This segment further extends its offerings with computer-aided design and manufacturing (CAD/CAM) services, essential accessories like disposable wand sleeves, iTero models and dies, and supports third-party scanners and digital scans. Noteworthy innovations include the Invisalign Outcome Simulator, a chairside and cloud-based application for the iTero scanner, the Invisalign Progress Assessment Tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans with current data. Align Technology distributes its products across global markets, including significant presence in the United States, Switzerland, and China. Established in 1997, the company maintains its corporate headquarters in Tempe, Arizona.
IPO date
Jan 26, 2001
Employees
22,910
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT